Johnson & Johnson’s J&J MedTech has received approval from the FDA for innovative products developed by Biosense Webster to enhance the treatment of atrial fibrillation. This condition causes irregular heartbeats and can have serious health implications. The approval allows for a “zero fluoroscopy workflow,” eliminating the need for live X-ray imaging during catheter insertion procedures. Instead, healthcare professionals can utilize ultrasound for guidance.
The reduction in the use of X-rays, or fluoroscopy, benefits both patients and medical professionals by minimizing radiation exposure. Healthcare providers specializing in heart procedures often face long-term risks due to excessive exposure to radiation, such as eye problems, cancer, and bone injuries. The FDA’s approval of this technology helps mitigate these occupational hazards. Additionally, medical personnel working in cath labs will no longer have to wear heavy protective gear like lead aprons when implementing this new workflow, reducing the risk of muscle and bone pain in the long run.
This FDA approval is a significant milestone, as it is the first and only one of its kind. The decision was based on data from clinical trials and the REAL AF Registry, which is a real-world evidence registry in the electrophysiology field. The data provided evidence of the effectiveness of this treatment in real-life scenarios. It is important to note that this approval applies specifically to Biosense products, including the widely used Thermocool SmartTouch SF catheter and others.
Denial of responsibility! TechCodex is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
Alex Smith is a writer and editor with over 10 years of experience. He has written extensively on a variety of topics, including technology, business, and personal finance. His work has been published in a number of magazines and newspapers, and he is also the author of two books. Alex is passionate about helping people learn and grow, and he believes that writing is a powerful tool for communication and understanding.
